Brand : JEIL Pharm

About Company

Founded in 1959, Jeil has developed and supplied superior pharmaceutical products to promote the happiness and health of mankind and has contributed to the growth and development of the pharmaceutical industry in Korea.

Jeil has been listed on KOSPI since 1988. As of 2018, Jeil is constituted of 1143 employees and has sales amount reaching above 680 billion Korean wons.

Website : https://www.jeilpharm.co.kr/english/

R&D

Jeil has set up research laboratories for three sectors, namely, Medicinal chemistry Lab/Pharmacology & Toxicology Lab for the invention of New Molecule Entities (NMEs), an Organic Synthesis laboratory for the development of high valued Active Pharmaceutical Ingredients (APIs), and a Pharmaceutical Technology Research Institute for the development of newly and Incrementally Modified Drugs (IMDs) using existing APIs.

All trademarks, tradenames, logos, copyrighted material such as text and/or images herein are the property of their respective owners, where applicable.